Inicio › Cáncer de pulmón de células no pequeñas › Kansas
Ensayos clínicos de Cáncer de pulmón de células no pequeñas en Kansas
33 estudios sobre Cáncer de pulmón de células no pequeñas buscan participantes en Kansas.
Ciudades en Kansas
- Overland Park16 estudios
- Kansas City11 estudios
- Salina7 estudios
- Olathe7 estudios
- Topeka7 estudios
- Lawrence6 estudios
- Hays6 estudios
- Wichita4 estudios
Texto oficial del estudio (inglés)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- The University of Kansas Cancer Center - Olathe, Olathe
- Cancer Center of Kansas - Pratt, Pratt
- Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT04267848Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
- Kansas City Cancer Center /ID# 273679, Overland Park
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06772623Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- The University of Kansas Cancer Center, Westwood
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06881784Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06498635A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
- University of Kansas Cancer Center, Westwood
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT05498428Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Research Site, Westwood
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06218914This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Saint Luke's South Hospital, Overland Park
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06758401A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- Research Site, Leawood
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06868277A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- University of Kansas Cancer Center, Fairway
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06667076Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Mercy Hospital Pittsburg, Pittsburg
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT03191149Pan-tumor MRD Study
- Cotton O'Neil Cancer Center [Stormont Vail], Topeka
- Cancer Center of Kansas, Wichita
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT06605404A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
- Cancer Center of Kansas, Wichita
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT06561386A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- University of Kansas, Westwood
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07020117Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- Local Institution - 007-942-B, Chanute
- Local Institution - 007-942-D, El Dorado
- Local Institution - 007-942-E, Independence
- y 12 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT04613596Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- University of Kansas Medical Center /ID# 263196, Westwood
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT06236438A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- The University of Kansas Cancer Center - Westwood, Westwood
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06119581Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- University of Kansas Medical Center, Kansas City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT06343402Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- University of Kansas Cancer Center, Kansas City
- University of Kansas Cancer Center-Overland Park, Overland Park
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT06500481A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The University of Kansas Cancer Center, Kansas City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT05592626Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- University of Kansas Medical Center (KUMC), Westwood
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 ago 2026 · NCT05579366A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- The University of Kansas Cancer Center, Investigational Drug Services, Fairway
- The University of Kansas Clinical Research Center, Fairway
- The University of Kansas Hospital, Kansas City
- y 6 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 jul 2026 · NCT04389632LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- University of Kansas Cancer Center, Westwood
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 jun 2026 · NCT06216301A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- The University of Kansas Cancer Center, Westwood
ReclutandoFase 1/2
Edades de 18 a 70 · Todos los sexos · Actualizado el 11 jun 2026 · NCT05361174Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- y 7 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 jun 2026 · NCT05642572Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- y 7 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 may 2026 · NCT06116682Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- y 8 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 may 2026 · NCT06616584Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- y 7 más
ReclutandoFase 2
18 Minutes · Todos los sexos · Actualizado el 5 may 2026 · NCT06031688A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- The University of Kansas Cancer Center, Fairway
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 mar 2026 · NCT06244771Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- y 6 más
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 mar 2026 · NCT06418204Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
- The University of Kansas Cancer Center (KUCC), Fairway
- The University of Kansas Cancer Center, Westwood Campus, Kansas City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 ene 2026 · NCT04467723A Study of IBI363 in Subjects with Advanced Solid Malignancies
- University of Kansas Medical Center (KUMC), Fairway
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 dic 2024 · NCT06281678Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients
- The University of Kansas Cancer Center, Westwood Campus, Kansas City
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 may 2024 · NCT04680377Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
- The University of Kansas Cancer Center (KUCC), Fairway
- The University of Kansas Cancer Center, Westwood Campus, Kansas City
ReclutandoEstudio observacional
Edades de 18 a 110 · Todos los sexos · Actualizado el 23 feb 2024 · NCT05332925De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.